ICU Medical Retained Earnings (Accumulated Deficit) 2010-2025 | ICUI

ICU Medical retained earnings (accumulated deficit) from 2010 to 2025. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
ICU Medical Annual Retained Earnings (Accumulated Deficit)
(Millions of US $)
2024 $690
2023 $808
2022 $838
2021 $912
2020 $809
2019 $722
2018 $621
2017 $586
2016 $517
2015 $454
2014 $409
2013 $383
2012 $342
2011 $301
2010 $256
2009 $228
ICU Medical Quarterly Retained Earnings (Accumulated Deficit)
(Millions of US $)
2025-03-31 $675
2024-12-31 $690
2024-09-30 $714
2024-06-30 $747
2024-03-31 $768
2023-12-31 $808
2023-09-30 $825
2023-06-30 $818
2023-03-31 $828
2022-12-31 $838
2022-09-30 $853
2022-06-30 $866
2022-03-31 $874
2021-12-31 $912
2021-09-30 $892
2021-06-30 $861
2021-03-31 $832
2020-12-31 $809
2020-09-30 $783
2020-06-30 $758
2020-03-31 $739
2019-12-31 $722
2019-09-30 $701
2019-06-30 $675
2019-03-31 $652
2018-12-31 $621
2018-09-30 $628
2018-06-30 $628
2018-03-31 $597
2017-12-31 $586
2017-09-30 $536
2017-06-30 $536
2017-03-31 $573
2016-12-31 $517
2016-09-30 $507
2016-06-30 $489
2016-03-31 $470
2015-12-31 $454
2015-09-30 $448
2015-06-30 $432
2015-03-31 $419
2014-12-31 $409
2014-09-30 $402
2014-06-30 $395
2014-03-31 $389
2013-12-31 $383
2013-09-30 $369
2013-06-30 $358
2013-03-31 $351
2012-12-31 $342
2012-09-30 $330
2012-06-30 $318
2012-03-31 $308
2011-12-31 $301
2011-09-30 $286
2011-06-30 $276
2011-03-31 $267
2010-12-31 $256
2010-09-30 $249
2010-06-30 $240
2010-03-31 $232
2009-12-31 $228
2009-09-30 $220
2009-06-30 $214
2009-03-31 $208
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $3.088B $2.382B
ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world's leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps, dedicated and non-dedicated IV sets and needlefree connectors, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, they manufacture automated pharmacy IV compounding systems with workflow technology, closed systems transfer devices for hazardous IV drugs, and cardiac monitoring systems to optimize patient fluid levels.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $223.656B 26.24
Boston Scientific (BSX) United States $157.946B 37.72
Stryker (SYK) United States $152.832B 31.96
EssilorLuxottica (ESLOY) France $137.378B 0.00
Medtronic (MDT) Ireland $117.532B 16.66
Lonza Group Ag (LZAGY) Switzerland $49.462B 0.00
Haleon (HLN) United Kingdom $43.306B 24.72
ResMed (RMD) United States $40.680B 30.56
Agilent Technologies (A) United States $33.534B 21.86
GE HealthCare Technologies (GEHC) United States $32.803B 15.37
Koninklijke Philips (PHG) Netherlands $25.816B 17.08
Terumo (TRUMY) Japan $25.125B 32.63
Insulet (PODD) United States $20.991B 82.39
Zimmer Biomet Holdings (ZBH) United States $18.463B 11.86
Baxter (BAX) United States $14.395B 10.75
Smith & Nephew SNATS (SNN) United Kingdom $13.547B 0.00
Sunny Optical Technology (SNPTF) China $10.417B 0.00
Demant (WILYY) Denmark $8.633B 0.00
Bio-Rad Laboratories (BIO) United States $6.805B 23.68
Lantheus Holdings (LNTH) United States $4.970B 12.54
Perrigo (PRGO) Ireland $3.781B 9.58
Prestige Consumer Healthcare (PBH) United States $3.713B 16.58
Haemonetics (HAE) United States $3.644B 16.60
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.383B 28.11
LeMaitre Vascular (LMAT) United States $1.852B 41.40
AtriCure (ATRC) United States $1.739B 0.00
QuidelOrtho (QDEL) United States $1.643B 11.30
Acuren (TIC) United States $1.391B 0.00
Green Thumb Industries (GTBIF) United States $1.271B 28.60
AdaptHealth (AHCO) United States $1.232B 12.51
Phibro Animal Health (PAHC) United States $1.132B 14.47
BioLife Solutions (BLFS) United States $1.044B 0.00
Neogen (NEOG) United States $1.019B 16.19
Curaleaf Holdings (CURLF) Canada $0.939B 0.00
InMode (INMD) Israel $0.879B 8.13
Kestra Medical Technologies (KMTS) United States $0.856B 0.00
Valneva SE (VALN) France $0.651B 0.00
Tilray Brands (TLRY) Canada $0.616B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.614B 0.00
Evolus (EOLS) United States $0.578B 0.00
Owens & Minor (OMI) United States $0.549B 4.56
CeriBell (CBLL) United States $0.539B 0.00
Surmodics (SRDX) United States $0.535B 0.00
ZimVie (ZIMV) United States $0.526B 20.52
SNDL (SNDL) Canada $0.378B 0.00
Capricor Therapeutics (CAPR) United States $0.374B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.342B 0.00
Cresco Labs (CRLBF) United States $0.315B 0.00
Sanuwave Health (SNWV) United States $0.308B 0.00
VAREX IMAGING (VREX) United States $0.307B 11.29
Quanterix (QTRX) United States $0.304B 0.00
Aurora Cannabis (ACB) Canada $0.254B 75.33
Cerus (CERS) United States $0.250B 0.00
Viemed Healthcare (VMD) United States $0.244B 20.60
OraSure Technologies (OSUR) United States $0.239B 0.00
Omeros (OMER) United States $0.238B 0.00
Biote (BTMD) United States $0.237B 6.68
Sanara MedTech (SMTI) United States $0.223B 0.00
Brainsway (BWAY) Israel $0.222B 58.75
Canopy Growth (CGC) Canada $0.215B 0.00
Verano Holdings (VRNOF) United States $0.215B 0.00
Exagen (XGN) United States $0.190B 0.00
Organigram Global (OGI) Canada $0.184B 0.00
Utah Medical Products (UTMD) United States $0.183B 15.07
Vireo Growth (VREOF) United States $0.177B 0.00
High Tide (HITI) Canada $0.172B 0.00
TriSalus Life Sciences (TLSI) United States $0.168B 0.00
TerrAscend (TSNDF) Canada $0.131B 0.00
FitLife Brands (FTLF) United States $0.117B 14.37
Jushi Holdings (JUSHF) United States $0.112B 0.00
Jin Medical (ZJYL) China $0.100B 0.00
Fonar (FONR) United States $0.098B 12.62
MacroGenics (MGNX) United States $0.097B 0.00
Quipt Home Medical (QIPT) United States $0.096B 0.00
Safety Shot (SHOT) United States $0.088B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Zynex (ZYXI) United States $0.075B 0.00
Veru (VERU) United States $0.072B 0.00
Apyx Medical (APYX) United States $0.072B 0.00
InterCure (INCR) Israel $0.067B 0.00
Agape ATP (ATPC) $0.064B 0.00
ImmuCell (ICCC) United States $0.058B 0.00
Cytosorbents (CTSO) United States $0.058B 0.00
Modular Medical (MODD) United States $0.038B 0.00
Nephros (NEPH) United States $0.037B 50.43
United-Guardian (UG) United States $0.036B 12.51
Rockwell Medical (RMTI) United States $0.033B 0.00
Allurion Technologies (ALUR) United States $0.020B 0.00
INLIF (INLF) $0.016B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Meihua Medical Technologies (MHUA) China $0.012B 0.00
Senestech (SNES) United States $0.011B 0.00
IM Cannabis (IMCC) Canada $0.011B 0.00
Innovative Eyewear (LUCY) United States $0.009B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Sharps Technology (STSS) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00